Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Perifosine: Phase I data

In an ongoing Phase I trial (Protocol 124) in 18

Read the full 106 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE